 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This is a signal that ACIU's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...

AC Immune SA (ACIU, $3.46) Stochastic Oscillator left the oversold zone on March 18, 2024

This is a Bearish indicator signaling ACIU's price could decline from here. Traders may explore shorting the stock or put options...

AC Immune SA (ACIU, $3.32) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 14, 2024

This price move could indicate a change in the trend, and may be a sell signal for investors...

AC Immune SA (ACIU, $3.32) price exceeded its 50-day Moving Average on March 14, 2024

AC Immune SA (ACIU, $3.32) Stochastic Oscillator left the oversold zone on March 14, 2024

This price move could be a signal that ACIU may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options...

AC Immune SA (ACIU, $3.32) price may climb as it broke lower Bollinger Band on Mar 14, 2024

AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update ACI-24.060 ABATE Phase 2 trial to report Abeta-PET imaging results in Q2 and H2ACI-7104.056 VacSYn Phase 2 trial in...

AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update

This price move could indicate a change in the trend, and may be a buy signal for investors...

AC Immune SA (ACIU, $3.7) price moved above its 50-day Moving Average on March 13, 2024

AC Immune SA (ACIU, $3.53) Stochastic Oscillator left the oversold zone on March 12, 2024

AC Immune SA (NASDAQ:ACIU  Free Report)  Stock analysts at Leerink Partnrs issued their FY2023 earnings per share (EPS) estimates for shares of AC Immune in a research note issued to...

Leerink Partnrs Comments on AC Immune SA's FY2023 Earnings (NASDAQ:ACIU)

This is a signal that ACIU's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...

AC Immune SA (ACIU, $3.43) Stochastic Oscillator left the overbought zone on March 11, 2024

AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.

Volume (M)	316,801.00
52-Wk High	$5.14
52-Wk Low	$1.78

ACIU AC Immune SA

About

Feed

News

Sentiment

Earnings

Fundamentals